SEC
SlamSEC
SearchBrowseEarnings

Catalent, Inc.

Pharmaceutical Preparations·SOMERSET, NJ
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1004 total)

TypeDateAccessionPeriodSize
15-12G
Dec 30, 2024
0001193125-24-28621615-12G
—
11.8 KB
4
Dec 18, 2024
0000950170-24-1377914
Dec 18, 2024
10.3 KB
4
Dec 18, 2024
0000950170-24-1377874
Dec 18, 2024
12.9 KB
4
Dec 18, 2024
0000950170-24-1377844
Dec 18, 2024
10.3 KB
4
Dec 18, 2024
0000950170-24-1377804
Dec 18, 2024
10.3 KB
4
Dec 18, 2024
0000950170-24-1377714
Dec 18, 2024
10.3 KB
4
Dec 18, 2024
0000950170-24-1377364
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377334
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377264
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377234
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377204
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377174
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377134
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377084
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377044
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1377014
Dec 18, 2024
6.2 KB
4
Dec 18, 2024
0000950170-24-1376604
Dec 18, 2024
26.9 KB
4
Dec 18, 2024
0000950170-24-1376594
Dec 18, 2024
24.9 KB
4
Dec 18, 2024
0000950170-24-1376584
Dec 18, 2024
12.9 KB
4
Dec 18, 2024
0000950170-24-1376574
Dec 18, 2024
14.4 KB
4
Dec 18, 2024
0000950170-24-1376564
Dec 18, 2024
12.8 KB
POSASR
Dec 18, 2024
0001193125-24-280981POSASR
—
20.1 KB
S-8 POS
Dec 18, 2024
0001193125-24-280977S-8 POS
—
20.4 KB
S-8 POS
Dec 18, 2024
0001193125-24-280974S-8 POS
—
20.4 KB
S-8 POS
Dec 18, 2024
0001193125-24-280969S-8 POS
—
20.4 KB
25 filings shown

It operates as an privately held independent subsidiary of Novo Holdings A/S. It is a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products.